Articles

Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab

Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan;
TAGCyx Biotechnologies Inc, Tokyo, Japan;
TAGCyx Biotechnologies Inc, Tokyo, Japan;
Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan;
Clinical Laboratory Medicine, Fujita Health University School of Medical Sciences, Toyoake, Japan
Department of Blood Transfusion Medicine, Nara Medical University, Kashihara, Japan;
Haematologica Early view Dec 19, 2019 https://doi.org/10.3324/haematol.2019.235549